Characteristics and in vitro anti-skin aging activity of gallic acid loaded in cationic CTAB niosome

Eur J Pharm Sci. 2019 Apr 1:131:39-49. doi: 10.1016/j.ejps.2019.02.008. Epub 2019 Feb 5.

Abstract

Physicochemical characteristics and in vitro anti-skin aging activity of gallic acid loaded in niosomes were investigated. Gallic acid was loaded in neutral (Brij 52/cholesterol at 7:3) and cationic CTAB niosomes (Brij 52/cholesterol/cetyltrimethylammonium bromide at 7:3:0.65). The maximum loading capacity and entrapment efficiency of gallic acid were 3.5, 4.48 ± 2.10 in neutral and 50%, w/w, 10.94 ± 0.78% in cationic CTAB niosomes, respectively. All gallic acid loaded in niosomes showed the unilamellar structure under transmission electron microscope with size range of 131.23-508.03 nm at initial and after storage for 3 months. The highest remaining percentage of gallic acid at all storage temperatures after 3 months was about 77% when loaded in the cationic CTAB niosome, whereas gallic acid in solution was about 64%. The release profiles of gallic acid loaded in neutral and cationic CTAB niosomes revealed the gradual release in 24 h. The cytotoxicity of gallic acid loaded in neutral and cationic CTAB niosomes appeared the non-cytotoxic effect in B16F10 melanoma cells and human skin fibroblasts. The cationic CTAB niosome loaded with gallic acid demonstrated the highest anti-skin aging activity, including melanin suppression effect (55.92 ± 4.92% of control) by inhibition of tyrosinase (53.18 ± 3.67% of control) and tyrosinase-related protein-2 (24.61 ± 7.92% of control), antioxidant (87.03 ± 0.99% cell viability) and inhibition of matrix metalloproteinase-2 (38.46 ± 1.53% of control). This study has demonstrated the superior stability and anti-skin aging activity of gallic acid loaded in cationic CTAB niosome for potential utilization in pharmaceutical and cosmetic products.

Keywords: Anti-aging; Cationic niosome; Cosmetics; Gallic acid; Melanogenesis.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cetrimonium / administration & dosage*
  • Cetrimonium / chemistry
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Gallic Acid / administration & dosage*
  • Gallic Acid / chemistry
  • Humans
  • Liposomes
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase Inhibitors / administration & dosage*
  • Matrix Metalloproteinase Inhibitors / chemistry
  • Melanins / metabolism
  • Mice
  • Skin / cytology
  • Skin Aging*

Substances

  • Liposomes
  • Matrix Metalloproteinase Inhibitors
  • Melanins
  • Gallic Acid
  • Matrix Metalloproteinase 2
  • Cetrimonium